AlphaTON Capital
We have no price for AlphaTON Capital since 18 June 2026. It may have been taken over, merged or renamed, so the figures below are from then.
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here.
Money in, money out
What AlphaTON Capital sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with -$6.77 million of profit last year.
AlphaTON Capital vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| AlphaTON Capital | No profit yet | ||
 Vertex Pharmaceuticals | 34.8× · Expensive | ||
 Regeneron Pharmaceuticals | 21.8× · Fair price | ||
 Moderna | No profit yet | ||
 CSL | 22.3× · Fair price |
AI analysis
An AI analyst reads AlphaTON Capital's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -16 | -17 | -18 | -7 | |
| -15 | -123 | -86 | -7 | |
| -17 | -105 | -75 | -7 | |
| -25.80 | -129.79 | -77.83 | -5.72 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 195 | 99 | 8 | 2 |
| Cash | 23 | 11 | 5 | 2 |
| Total debt | – | 0 | 0 | 0 |
| Total liabilities | 29 | 24 | 4 | 3 |
| 121 | 76 | 4 | -0 | |
| 1 | 1 | 1 | 1 | |
| -9.6% | -127.3% | -1,667.7% | – | |
| -13.9% | -137.6% | -1,873.2% | 5,501.6% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -7 | -12 | -14 | -5 | |
| – | 0 | – | – | |
| -7 | -12 | -14 | -5 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 9 | 4 | 3 | 0 |
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
What analysts expect
- Average price target
- $4.88
- Range
- $4.50 – $5.25
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Jan 12, 2026 | -4.13 | -0.35 | −1,080.0% |
| Jan 5, 2026 | -1.26 | -4.20 | +70.0% |
| Oct 8, 2025 | -2.57 | – | – |
| Mar 28, 2025 | -0.17 | – | – |
| Nov 26, 2024 | -1.26 | – | – |
| Aug 27, 2024 | -1.58 | – | – |
| Jun 6, 2024 | -1.26 | -0.22 | −471.8% |
| Feb 28, 2024 | -3.60 | -5.40 | +33.3% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about AlphaTON Capital
Is AlphaTON Capital a good stock to buy?
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the AlphaTON Capital AI analysis
What does AlphaTON Capital do?
AlphaTON Capital Corp. operates as a digital asset treasury company. It focuses on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. It is in Biotechnology.
Does AlphaTON Capital pay a dividend?
No. AlphaTON Capital does not pay a dividend at the moment.
Who are AlphaTON Capital's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Moderna and CSL. The peers table on this page compares their profit, growth and price with AlphaTON Capital's.
Prices: daily closes to Jun 18, 2026. Fundamentals: company reports via invest-like data.